Cingulate CING
NASDAQ CING
$5.55 +0.22 (+4.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cingulate (CING) Payables (2021 - 2026)

Cingulate's (CING) quarterly Payables came in at $8.3 million in Q4 2025, up 119.4% YoY from $3.8 million in Q4 2024, and up 105.67% on a QoQ basis from $4.1 million in Q3 2025.

Cingulate (CING) Payables (2021 - 2026) Analysis & Trends

Cingulate (CING) has 5 years of Payables data on file, last reported at $8.3 million in Q4 2025.

  • Quarterly Payables rose 119.4% year-over-year to $8.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.3 million (up 119.4% YoY) and the FY2025 annual result came in at $8.3 million, up 119.4% from the prior year.
  • Payables rose to $8.3 million in Q4 2025, from $4.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $9.6 million in Q2 2023 to a low of $264687.0 in Q4 2021.
  • A 5-year average of $4.0 million and a median of $4.4 million in 2023 frame the typical range for Payables.
  • Annual changes were most pronounced in 2023 — Payables jumped 3305.39% — and 2024, when it tumbled 86.82%.
  • Tracing CING's Payables over 5 years: stood at $264687.0 in 2021, then soared by 2077.05% to $5.8 million in 2022, then surged by 42.29% to $8.2 million in 2023, then slumped by 53.69% to $3.8 million in 2024, then soared by 119.4% to $8.3 million in 2025.
  • The last three Payables figures came in at $8.3 million (Q4 2025), $4.1 million (Q3 2025), and $5.0 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 167.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 470.30 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 108.02 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 622.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 428.93 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 35.57 Mn
10 Cingulate 72.85 Mn 72.85 Mn - 7.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.05 Mn
Dec 31, 2025 8.33 Mn
Sep 30, 2025 4.05 Mn
Mar 31, 2025 4.98 Mn
Dec 31, 2024 3.80 Mn
Sep 30, 2024 906,215.00
Jun 30, 2024 1.33 Mn
Mar 31, 2024 737,949.00
Dec 31, 2023 8.20 Mn
Sep 30, 2023 4.67 Mn
Jun 30, 2023 9.61 Mn
Mar 31, 2023 5.60 Mn
Dec 31, 2022 5.76 Mn
Sep 30, 2022 5.39 Mn
Jun 30, 2022 282,265.00
Mar 31, 2022 556,326.00
Dec 31, 2021 264,687.00